Moreover, despite adenocarcinomas showing the highest EGFR mutation rate among all histological cancer types, we included all patients with lung cancer, unlike other studies that exclusively selected patients with NSCLC or adenocarcinoma. This evidence concerns the gene EGFR and lung cancer.